TCMBANKIN022246 |
Spectabiline |
Spectabiline (8CI); spectabiline; 520-55-8; 20-Norcrotalanan-11,15-dione, 13-(acetyloxy)-14,19-dihydro-12-hydroxy-, (13alpha,14alpha)- (9CI); NSC 89934 |
C18H25NO7 |
367.39 |
CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)OC(=O)C)(C)O |
TCMBANKIN057976 |
SPD;spermidine |
124-20-9 (FREE BASE); KBioSS_000345; Lopac0_001047; SPBio_000947; 4-04-00-01300 (Beilstein Handbook Reference); BRN 1698591; 85561_FLUKA; NCI60_004294; Spermidine 0.1 M solution; Spermidine solution; 1,8-Diamino-4-azaoctane; KBio2_005481; 05292_FLUKA; IDI1_001007; 334-50-9 (TRIHYDROCHLORIDE); NCGC00015937-01; NCGC00024903-03; Spectrum3_000977; NSC528399 (TRIHYDROCHLORIDE); SDCCGMLS-0066822.P001; Lopac-S-2501; SPERMIDINE; KBio3_001833; 1,5,10-Triazadecane; 1,4-Diaminobutane, N-(3-aminopropyl)-; Spermidin; N-(2-AMINO-PROPYL)-1,4-DIAMINOBUTANE; S2626_SIGMA; AIDS005223; Spectrum4_001101; 85558_FLUKA; KBio1_001007; Spectrum2_000874; N-(3-Aminopropyl)-1,4-diaminobutane; N-(3-Aminopropyl)-1,4-butanediamine; 4-aminobutyl-(3-aminopropyl)amine; DivK1c_001007; NINDS_001007; Spectrum5_001561; Spectrum_000005; AI3-26636; N-(3-aminopropyl)butane-1,4-diamine; KBio2_000345; S4139_SIGMA; KBioGR_001542; EINECS 204-689-0; 124-20-9; AIDS-005223; Tocris-0959; PA(34); Additive Screening Solution 30/Fluka kit no 78374; KBio2_002913; 4-azaoctane-1,8-diamine; 4-Azaoctamethylenediamine; C00315; BPBio1_001276; BSPBio_002613; NCGC00024903-01; N-(3-Aminopropyl)-1,4-butane-diamine; 1,4-Butanediamine, N-(3-aminopropyl)-; S0266_SIGMA; CHEBI:16610; Biomol-NT_000212;AKOS024427000; 7712AH; API0004220; 2C7H19N3.3H3O4P; S0385; BG01192050; MFCD00043283; Dispermidine triphosphate; tris(phosphoric acid); bis(spermidine); MCULE-6635730810 |
C7H19N3 |
145.25 g/mol |
C(CCNCCCN)CN |